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Evidence-based medicine is supposed to be a conclusive
summary of available empirical knowledge on certain
medical issues and as such serving as the basis of guide-
lines and treatment recommendations. Meant to be self-
explaining, the term actually appears to be crucial. It seems
inconsistent and inconclusive since recommendations of
single countries/institutions are based on different evidence
measures—some derive evidence from meta-analyses,
whereas others exclusively follow randomised controlled
studies. In a philosophical side trip, Mo ¨ller [1] critically
highlights these internationally different measures upon
which grading of evidence is levelled and claims a uniform
evidence grading.
In mild major, minor or subsyndromal depression, the
total score of the Hamilton Depression Rating Scale
(HAMD) so far is regarded as ‘gold standard’ in evaluating
efﬁcacy of antidepressant treatment. Nevertheless, in
comparing the full scales HAMD17 and the Inventory of
Depressive Symptomatology (IDS-C28) plus diverse uni-
dimensional subcales in a randomised, placebo-controlled
trial in a representative patient sample, Helmreich et al. [2]
found the full scales outmatching subscales and the IDS to
be superior to the HAMD in detecting symptom changes.
Although the time- and cost-saving subscales are able to
judge drug therapy outcomes, they fail in covering all
depression facets for which reason the cost-to-beneﬁt ratio
should be carefully assessed in the decision against using
full scales.
In the pathophysiology of depression, glutamate plays an
important role. Exploring the association of major depres-
sive disorder with some single nucleotide polymorphisms
within the glutamatergic AMPA receptor subunits GRIA1,
GRIA2 and GRIA4, Chiesa et al. [3] in a relatively small
patient sample genotyped Korean inpatients with major
depressive disorder in order to possibly predict clinical
outcomes. Although no association between alleles, geno-
types and haplotypes under investigation plus clinical and
demographical variables was detectable, the group found
evidence for a possible association between the single
nucleotide polymorphisms rs4302506, rs4403097 within
GRIA2 and age of depression onset. Anyhow, these results
should be substantiated in larger cohorts.
Although an association between affective disorders and
the metabolic syndrome has been suspected, past studies
did not bear clear results in this respect. Hence, Kahl et al.
[4] have examined the prevalence of the metabolic syn-
drome in 230 male and female inpatients with unipolar
major depressive disorder compared to 1,673 controls from
primary care from a similar northern German region using
the AHA/NHBLI criteria to determine rate and each single
criterion of the metabolic syndrome. The inpatient group
showed a 2.49 as high prevalence of the metabolic syn-
drome versus data from controls and elevations for fasting
glucose and triglycerides in both genders plus waist cir-
cumference in women. Men in both study groups again had
higher rates of increased fasting glucose and triglycerides
than women. Furthermore, the authors found an association
between severity of depression and metabolic syndrome in
inpatients and postulate better treatment interventions for
metabolic abnormalities and screening for physical health
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DOI 10.1007/s00406-012-0324-9conditions in patients with major depression. Not only due
to seasonality, 25-hydroxyvitamin D and hormone levels
may be important in the development of depression. To
investigate whether the association between depression and
low serum 25-hydroxyvitamin D (25(OH)D) and elevated
serum parathyroid hormone (PTH) in clinical settings also
applies to individuals beyond, Jaddou et al. [5] in a Jorda-
nian national population-based household sample screened
4,002 individuals for depression with the DASS21 depres-
sion scale and measured serum concentrations of 25(OH)D
and PTH by radioimmunoassay. They found a statistically
signiﬁcant relationship between serum 25(OH)D and
depression, but not forPTH. Since the decrease inthe risk of
depression among participants became signiﬁcant with
serum 25(OH)D levels higher than 42.3 ng/ml, reaching the
desirable level might be helpful in preventing and treating
depression.
Cognitive deﬁcits play a major role in psychiatric dis-
orders like depression and schizophrenia, but also in neu-
rodegenerative diseases. In an fMRI study in healthy
probands, Voss et al. [6] investigated the contribution of the
muscarinic receptor system on cognitive performance via
applying scopolamine and found hypoactivations in parie-
tal, occipital and cerebellar areas plus in frontal and pre-
frontal areas. Their results speak for a contribution of
muscarinic transmission on cerebral activation. Cholines-
terase inhibitors are widely used in the therapy of cognitive
deﬁcits in Alzheimer’ disease. Since diffusion tensor
imaging (DTI) has shown a decline of fractional anisotropy
as marker of ﬁbre tract integrity in Alzheimer’s disease,
Likitjaroen et al. [7] compared the longitudinal course of
white matter microstructural changes in patients with Alz-
heimer’s disease and healthy elderly controls and evaluated
treatment effects with the cholinesterase inhibitor galanta-
mine versus placebo in the patient group. Despite a seem-
ingly signiﬁcant decline of fractional anisotropy in certain
brain regions after 6-month follow-up, at 12-month follow-
up, the impact of galantamine was only limited and
between-group differences across patients and controls
were no longer detectable.
DTI also was used by Konrad et al. [8] to investigate 12
white matter regions-of-interest within the attentional net-
work of adult patients with attention-deﬁcit/hyperactivity
disorder (ADHD) compared to healthy controls. Addi-
tionally, all subjects underwent clinical interviews, rating
scales and neuropsychological tests. Their ﬁndings support
a disturbed frontostriatal structural connectivity and an
involvement of the left temporal white matter to be
responsible for attentional deﬁcits.
In all, cognitive deﬁcits are core symptoms of psychi-
atric disorders and responsible for an unfavourable out-
come. The investigation of the neurobiological basis of
these symptoms is needed to develop new regenerative
treatment strategies in psychiatric and neurodegenerative
diseases.
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